UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000045961
Receipt No. R000052462
Scientific Title Impact of gastrectomy for incurable advanced gastric cancer in the elderly
Date of disclosure of the study information 2021/11/02
Last modified on 2021/11/09 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Impact of gastrectomy for incurable advanced gastric cancer in the elderly
Acronym Palliative gastrectomy in the elderly
Scientific Title Impact of gastrectomy for incurable advanced gastric cancer in the elderly
Scientific Title:Acronym Palliative gastrectomy in the elderly
Region
Japan

Condition
Condition Gastric cancer
Classification by specialty
Gastrointestinal surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To investigate the significance of gastrectomy as a palliative surgery in elderly patients with incurable advanced gastric cancer
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Overall survival after surgery
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
80 years-old <=
Age-upper limit
92 years-old >=
Gender Male and Female
Key inclusion criteria We included 56 patients aged >80 years with incurable advanced gastric cancer who required surgical intervention at our department between February 1992 and July 2021. All patients were diagnosed with stage IV disease with at least one non-curative resection factor (non-resectable distant metastases, para-aortic lymph node metastasis above the celiac axis or below the inferior mesenteric artery or both, or non-resectable peritoneal carcinosis).
Key exclusion criteria Twenty-six patients with gastric cancer of the upper part of the stomach, and three who underwent procedure other than gastrectomy or bypass (partial gastrectomy [n = 1] and gastrostomy [n = 2]) were excluded.
Target sample size 56

Research contact person
Name of lead principal investigator
1st name Hiroshi
Middle name
Last name Kusanagi
Organization Kameda Medical Center
Division name Gastroenterological surgery
Zip code 296-0041
Address 929, Higashicho, Kamogawa, Chiba, Japan
TEL 04-7092-2211
Email kusanagi.hiroshi@kameda.jp

Public contact
Name of contact person
1st name Goshi
Middle name
Last name Fujimoto
Organization Koga Community Hospital
Division name Gastroenterological surgery
Zip code 425-0088
Address 2-30-1, Daikakuji, Yaizu, Shizuoka 425-0088, Japan
TEL 054-628-5500
Homepage URL
Email g_chimera_7@yahoo.co.jp

Sponsor
Institute Kameda Medical Center
Gastroenterological surgery
Institute
Department

Funding Source
Organization not applicable
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kameda Medical Center
Address 929, Higashicho, Kamogawa, Chiba, Japan
Tel 04-7092-2211
Email kusanagi.hiroshi@kameda.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 11 Month 02 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 56
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures Overall survival after surgery
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2021 Year 08 Month 17 Day
Date of IRB
2021 Year 08 Month 24 Day
Anticipated trial start date
2021 Year 08 Month 17 Day
Last follow-up date
2021 Year 08 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information We included 56 patients aged >80 years with incurable advanced gastric cancer who required surgical intervention at our department between February 1992 and July 2021. All patients were diagnosed with stage IV disease with at least one non-curative resection factor (non-resectable distant metastases, para-aortic lymph node metastasis above the celiac axis or below the inferior mesenteric artery or both, or non-resectable peritoneal carcinosis). Twenty-six patients with gastric cancer of the upper part of the stomach, and three who underwent procedure other than gastrectomy or bypass (partial gastrectomy [n = 1] and gastrostomy [n = 2]) were excluded. The patients' characteristics, surgical and pathological findings, and postoperative clinical courses were retrieved from medical records and databases at our institution.

Management information
Registered date
2021 Year 11 Month 02 Day
Last modified on
2021 Year 11 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052462